Stockreport

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine candidate BNT113 based on Bi [Read more]